Point72 Middle East Fze Atea Pharmaceuticals, Inc. Transaction History

Point72 Middle East Fze

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$2.8 - $3.35 $30,634 - $36,652
10,941 Added 495.74%
13,148 $40,000
Q3 2023

Nov 14, 2023
SELL
$3.0 - $3.79 $19,125 - $24,161
-6,375 Reduced 74.28%
2,207 $6,000
Q2 2023

Aug 14, 2023
BUY
$3.21 - $5.06 $27,548 - $43,424
8,582 New
8,582 $32,000
Q4 2022

Feb 14, 2023
BUY
$4.35 - $6.17 $9,948 - $14,110
2,287 New
2,287 $0

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $275M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email